1. In Vivo
  2. >>Deal-Making

Deals Shaping The Medical Industry, March 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced February 2015.

Novigenix SA acquired fellow private Swiss molecular diagnostics firm Diagnoplex SA, and now has full control of the Colox colorectal cancer diagnostic. (Feb.)

Details of the transaction were not released. Colox is a blood-based test that analyzes the expression of 29 different genes in peripheral blood mononuclear cells, which are responsive to growing adenomatous polyps and colorectal carcinomas

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deal-Making

More from In Vivo